TABLE OF CONTENTS
Volume 66, Issue 4 (October 1999)
Pharmacokinetics and Drug Disposition |
Pharmacodynamics and Drug Action |
Pharmacogenetics and Genomics
Commentaries
Omission of authors
Clin Pharmacol Ther 66: 333; doi:10.1053/cp.1999.v66.a101062b
The case of the forgotten author: A mystery to editors
June Reidenberg MA
Clin Pharmacol Ther 66: 334-335; doi:10.1053/cp.1999.v66.a101062
The Molecular Therapeutics Section of the American Society for Clinical Pharmacology and Therapeutics
Scott A. Waldman MD, PhD, FCP and Andre Terzic MD, PhD
Clin Pharmacol Ther 66: 336-337; doi:10.1053/cp.1999.v66.a100878
Pharmacokinetics and Drug Disposition
Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum)
Andreas Johne MD, Jürgen Brockmöller MD, Steffen Bauer PhD, Agathe Maurer MD, Matthias Langheinrich MD and Ivar Roots MD
Clin Pharmacol Ther 66: 338-345; doi:10.1053/cp.1999.v66.a101944
Development of in vivo bioequivalence methodology for dermatologic corticosteroids based on pharmacodynamic modeling
Gur Jai Pal Singh PhD, Wallace P. Adams PhD, Lawrence J. Lesko PhD, Vinod P. Shah PhD, Justina A. Molzon MS, JD, Roger L. Williams MD and Lynn K. Pershing PhD
Clin Pharmacol Ther 66: 346-357; doi:10.1053/cp.1999.v66.a101209
Grapefruit juice has minimal effects on plasma concentrations of lovastatin-derived 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors
John D. Rogers PhD, Jamie Zhao PhD, Lida Liu MS, Raju D. Amin BS, Kathleen D. Gagliano BS, MEd, Arturo G. Porras PhD, Robert A. Blum PharmD, Michael F. Wilson MD, Michael Stepanavage MS and Jose M. Vega MD
Clin Pharmacol Ther 66: 358-366; doi:10.1053/cp.1999.v66.a101208
Time course and extent of angiotensin II antagonism after irbesartan, losartan, and valsartan in humans assessed by angiotensin II dose response and radioligand receptor assay
Gustav G. Belz MD, PhD, Raunhild Butzer MD, Susan Kober PhD, Christian Mang MD and Ernst Mutschler MD, PhD
Clin Pharmacol Ther 66: 367-373; doi:10.1053/cp.1999.v66.a101162
Ketoconazole inhibits the clearance of the enantiomers of the antidepressant reboxetine in humans
Beth D. Herman BS, Joseph C. Fleishaker PhD and Mark T. Brown MD
Clin Pharmacol Ther 66: 374-379; doi:10.1053/cp.1999.v66.a101207
Pharmacokinetics and pharmacodynamics of dichloroacetate in patients with cirrhosis
Robert E. Shangraw MD, PhD and Dennis M. Fisher MD
Clin Pharmacol Ther 66: 380-390; doi:10.1053/cp.1999.v66.a101340
Longitudinal assessment of a P-glycoprotein–mediated drug interaction of valspodar on digoxin
John M. Kovarik PhD, Laurence Rigaudy PhD, Madeleine Guerret PhD, Christophe Gerbeau PhD and Karl-Ludwig Rost PhD
Clin Pharmacol Ther 66: 391-400; doi:10.1053/cp.1999.v66.a101462
Mibefradil but not isradipine substantially elevates the plasma concentrations of the CYP3A4 substrate triazolam
Janne T. Backman MD, Jun-Sheng Wang MD, Xia Wen MD, Kari T. Kivistö MD and Pertti J. Neuvonen MD
Clin Pharmacol Ther 66: 401-407; doi:10.1053/cp.1999.v66.a101461
The effect of grapefruit juice on the time-dependent decline of artemether plasma levels in healthy subjects
Michiel A. van Agtmael MD, Veenu Gupta BS, Chantal A. A van der Graaf BS and Chris J. van Boxtel MD, PhD
Clin Pharmacol Ther 66: 408-414; doi:10.1053/cp.1999.v66.a101946
Pharmacodynamics and Drug Action
Effect of filgrastim treatment on inflammatory cytokines and lymphocyte functions
Thomas Hartung MD, PhD, Wolf-Dietrich Doecke MD, Daniela Bundschuh PhD, MaryAnn Foote PhD, Florian Gantner PhD, Corinna Hermann MS, Andre Lenz, Steven Milwee PhD, Bill Rich MS, Bernadett Simon MS, Hans-Dieter Volk MD, PhD, Sonja von Aulock and Albrecht Wendel PhD
Clin Pharmacol Ther 66: 415-424; doi:10.1053/cp.1999.v66.a101210
Meloxicam, 15 mg/day, spares platelet function in healthy volunteers
Arthur de Meijer MD, Hans Vollaard PhD, Menno de Metz PhD, Bert Verbruggen, Chris Thomas PhD and Irena Novakova MD, PhD
Clin Pharmacol Ther 66: 425-430; doi:10.1053/cp.1999.v66.a101063
Pharmacogenetics and Genomics
Flavin monooxygenase 3 (FMO3) polymorphism in a white population: Allele frequencies, mutation linkage, and functional effects on clozapine and caffeine metabolism
Christoph Sachse PhD, Steffen Ruschen, Michael Dettling MD, Jürgen Schley DSc, Steffen Bauer PhD, Bruno Müller-Oerlinghausen MD, Ivar Roots MD and Jürgen Brockmöller MD
Clin Pharmacol Ther 66: 431-438; doi:10.1053/cp.1999.v66.a102203
